The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Voronkova K.V.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Pylaeva O.A.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Kosiakova E.S.

Kafedra nevrologii i neĭrokhirurgii pediatricheskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Mazal'skaia O.V.

Kafedra nevrologii i neĭrokhirurgii pediatricheskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Golosnaia G.S.

Kafedra nevrologii i neĭrokhirurgii pediatricheskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Provatorova M.A.

Moskovskiĭ oblastnoĭ konsul'tativno-diagnosticheskiĭ tsentr dlia deteĭ

Koroleva N.Iu.

Institut mozga cheloveka im. N.P. Bekhterevoĭ RAN, Sankt-Peterburg

Akhmedov T.M.

Gorodskaia poliklinika N1 im. A.G. Kiazimova, Baku, Respublika Azerbaĭdzhan

Anan'eva T.V.

Nauchno-prakticheskiĭ tsentr meditsinskoĭ pomoshchi detiam s porokami razvitiia cherepno-litsevoĭ oblasti i vrozhdennymi zabolevaniiami nervnoĭ sistemy, Baku, Respublika Azerbaĭdzhan

Petrukhin A.S.

Kafedra nervnykh bolezneĭ pediatricheskogo fakul'teta s kursom fakul'teta usovershenstvovaniia vracheĭ Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

Modern principles of epilepsy therapy

Authors:

Voronkova K.V., Pylaeva O.A., Kosiakova E.S., Mazal'skaia O.V., Golosnaia G.S., Provatorova M.A., Koroleva N.Iu., Akhmedov T.M., Anan'eva T.V., Petrukhin A.S.

More about the authors

Read: 11134 times


To cite this article:

Voronkova KV, Pylaeva OA, Kosiakova ES, et al. Modern principles of epilepsy therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(6):24‑36. (In Russ.)

Recommended articles:
The effect of a gami­fication on healthy indi­viduals’ motor acti­vity. Russian Journal of Preventive Medi­cine. 2025;(4):111-116
Key specific tools for asse­ssment of life quality of patients with psoriasis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):319-325
Dysfunctional pelvic pain in women. Russian Journal of Pain. 2025;(2):32-37
Quality of life after prophylactic mastectomy with simu­ltaneous reco­nstruction. Plastic Surgery and Aesthetic Medi­cine. 2025;(2-2):5-12

References:

  1. Voronkova K.V., Petrukhin A.S., Pylaeva O.A., Kholin A.S. Ratsional'naya antiepilepticheskaya farmakologiya. Rukovodstvo dlya vrachei. M: Binom press 2008; 192.
  2. Battino D., Croci D, Rossini A. et al. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data. Clin Pharmacokinet 2005; 44: 407-416.
  3. Berkovic S.F., Knowiton R.C., Leroy R.F. et al. (Levetiracetam N01057 Stady Group). Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007; 69: 18: 1751-1760.
  4. Brodie M.J., Perucca E., Ryvlin P. et al. (Levetiracetam Monotherapy Stady Group). Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007; 68: 402-408.
  5. Deckers C.L., Knoester P.D., de Haan G.J. et al. Selection criteria for the clinical use of the newer antiepileptic drugs. CNS Drugs 2003; 17: 405-421.
  6. Dickersin K., Straus S.E., Bero L.A. Evidence based medicine: increasing, not dictating, choice. BMJ 2007; 334 (Suppl 1): 10.
  7. French J.A., Kanner A.M., Bautista J. et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62: 1252-1260.
  8. Glauser T., Ben-Menachem E., Bourgeois B. et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial .monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094-1120.
  9. Glauser T.A., Pippenger C.E. Controversies in blood-level monitoring: reexamining its role in the treatment of epilepsy. Epilepsia 2000; 41 (Suppl 8): 6-15.
  10. Guidelines for therapeutic monitoring on antiepileptic drugs. Commission on Antiepileptic Drugs, International League Against Epilepsy. Epilepsia 1993; 34: 585-587.
  11. Jannuzzi G., Cian P., Fattore C. et al. A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy. Epilepsia 2000; 41: 222-230.
  12. Johannessen S.I., Battino D., Berry D.J. et al. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 2003; 25: 347-363.
  13. Kwan P., Brodie M.J. Effectiveness of first antiepileptic drug. Epilepsia 2001; 42: 1255-1260.
  14. Lesser R.P. Psychogenic seizures. Neurology 1996; 46: 1499-1507.
  15. Lynch B.A., Lambeng N., Nocka K. et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004; 101: 9861-9866.
  16. Noachtar S., Andermann E., Meyviscle P. et al. (N166 Levetiracetam Study Group). Levetiracetam for the threatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008; 70: 607-618.
  17. Panayotopoulos Principles of Therapy in the Epilepsies. A Clinical Guide to Epileptic Syndromes and their Treatment. Springer 2007: 155-184.
  18. Patsalos P.N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 2000; 85: 77-85.
  19. Patsalos P.N. The pharmacokinetic characteristics of levetiracetam. Methods Find Exp Clin Pharmacol 2003; 25: 123-129.
  20. Privitera M.D., Brodie M.J., Mattson R.H. et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003; 107: 165-175.
  21. Schmidt D., Elger C., Holmes G.L. Pharmacological overtreatment in epilepsy: mechanisms and management. Epilep Res 2002; 52: 3-14.
  22. Tomson T., Battino D. Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 2007; 46: 209-219.
  23. Tomson T., Dahl M., Kimland E. Therapeutic monitoring of antiepileptic drugs for epilepsy. Cochrane Database Syst Rev 2007; 1: CD002216.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.